Mumbai: As China restarts manufacturing activity, including for pharmaceutical raw material, rating agency Icra has revised its outlook for the Indian pharma sector to ‘stable’ from ‘negative’ earlier. When Icra revised the rating earlier this year, the fear was that a shutdown in China prompted by the Covid-19 pandemic would […]

Tags